{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T10:27:45Z","timestamp":1793874465959,"version":"4.6.1"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T00:00:00Z","timestamp":1624579200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"abstract":"<jats:p>The whole world is suffering from the coronavirus disease 2019 (COVID-19) pandemic, induced by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) through angiotensin-converting enzyme 2 (ACE2). Neurological manifestations in COVID-19 patients suggested the invasion of SARS-CoV-2 into the central nervous system. The present study mapped the expression level of ACE2 in 12 brain regions through immunohistochemistry and detected ACE2 in endothelial cells and non-vascular cells. The comparison among brain regions found that pons, visual cortex, and amygdala presented a relatively high level of ACE2. In addition, this study demonstrates that the protein level of ACE2 was downregulated in the basal nucleus, hippocampus and entorhinal cortex, middle frontal gyrus, visual cortex, and amygdala of the brain with Alzheimer\u2019s disease (AD) pathology. Collectively, our results suggested that ACE2 was expressed discriminatorily at different human brain regions, which was downregulated in the brain with AD pathology. This may contribute to a comprehensive understanding of the neurological symptoms caused by SARS-CoV-2 and provide clues for further research on the relationship between COVID-19 and AD.<\/jats:p>","DOI":"10.3389\/fcell.2021.684874","type":"journal-article","created":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T04:33:05Z","timestamp":1624595585000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":43,"title":["The Altered Anatomical Distribution of ACE2 in the Brain With Alzheimer\u2019s Disease Pathology"],"prefix":"10.3389","volume":"9","author":[{"given":"Huan","family":"Cui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenying","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,6,25]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2020.588872","article-title":"Cognitive and neuropsychiatric manifestations of COVID-19 and effects on elderly individuals with dementia.","volume":"12","author":"Alonso-Lana","year":"2020","journal-title":"Front. Aging Neurosci."},{"key":"B2","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.bbi.2020.04.077","article-title":"COVID-19 presenting as stroke.","volume":"87","author":"Avula","year":"2020","journal-title":"Brain Behav. Immun."},{"key":"B3","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1021\/acschemneuro.0c00122","article-title":"Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms.","volume":"11","author":"Baig","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"B4","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20202014","article-title":"ACE\/ACE2 balance might be instrumental to explain the certain comorbidities leading to severe COVID-19 cases.","volume":"41","author":"Bank","year":"2021","journal-title":"Biosci. Rep."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.117905","article-title":"Protective role of ACE2 and its downregulation in SARS-CoV-2 infection leading to Macrophage activation syndrome: therapeutic implications.","volume":"256","author":"Banu","year":"2020","journal-title":"Life Sci."},{"key":"B6","first-page":"1","article-title":"COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection.","volume":"21","author":"Beyerstedt","year":"2021","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.573095","article-title":"The spatial and cell-type distribution of SARS-CoV-2 receptor ACE2 in the human and mouse brains.","volume":"11","author":"Chen","year":"2021","journal-title":"Front. Neurol."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2020.101205","article-title":"Aging in COVID-19: vulnerability, immunity and intervention.","volume":"65","author":"Chen","year":"2021","journal-title":"Ageing Res. Rev."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22041687","article-title":"Protein expression of angiotensin-converting enzyme 2 (ACE2) is upregulated in brains with Alzheimer\u2019s disease.","volume":"22","author":"Ding","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B10","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1161\/01.RES.87.5.e1","article-title":"A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9.","volume":"87","author":"Donoghue","year":"2000","journal-title":"Circ. Res."},{"key":"B11","doi-asserted-by":"crossref","first-page":"R373","DOI":"10.1152\/ajpregu.00292.2006","article-title":"Differential expression of neuronal ACE2 in transgenic mice with overexpression of the brain renin-angiotensin system.","volume":"292","author":"Doobay","year":"2007","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3233\/jad-200581","article-title":"Neurobiology of COVID-19.","volume":"76","author":"Fotuhi","year":"2020","journal-title":"J. Alzheimers Dis."},{"key":"B13","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China.","volume":"382","author":"Guan","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/path.1570","article-title":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis.","volume":"203","author":"Hamming","year":"2004","journal-title":"J. Pathol."},{"key":"B15","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor.","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"B16","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41579-020-00459-7","article-title":"Characteristics of SARS-CoV-2 and COVID-19.","volume":"19","author":"Hu","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"B17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","article-title":"National institute on aging-Alzheimer\u2019s association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease.","volume":"8","author":"Hyman","year":"2012","journal-title":"Alzheimers Dement"},{"key":"B18","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-020-01957-4","article-title":"Neurological consequences of COVID-19: what have we learned and where do we go from here?","volume":"17","author":"Jarrahi","year":"2020","journal-title":"J. Neuroinflam."},{"key":"B19","doi-asserted-by":"publisher","first-page":"96","DOI":"10.2174\/1567202613666160224124739","article-title":"Plasma angiotensin-(1\u20137) is a potential biomarker for Alzheimer\u2019s disease.","volume":"13","author":"Jiang","year":"2016","journal-title":"Curr. Neurovasc. Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.3233\/jad-171119","article-title":"The coming of age of the angiotensin hypothesis in Alzheimer\u2019s disease: progress toward disease prevention and treatment?","volume":"62","author":"Kehoe","year":"2018","journal-title":"J. Alzheimers Dis."},{"key":"B21","doi-asserted-by":"crossref","DOI":"10.1186\/s13195-016-0217-7","article-title":"Angiotensin-converting enzyme 2 is reduced in Alzheimer\u2019s disease in association with increasing amyloid-\u03b2 and tau pathology.","volume":"8","author":"Kehoe","year":"2016","journal-title":"Alzheimers Res. Ther."},{"key":"B22","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.59136","article-title":"Neuropathogenesis of SARS-CoV-2 infection.","volume":"9","author":"Khan","year":"2020","journal-title":"Elife"},{"key":"B23","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/nm1267","article-title":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury.","volume":"11","author":"Kuba","year":"2005","journal-title":"Nat. Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1093\/gerona\/glaa131","article-title":"APOE e4 genotype predicts severe COVID-19 in the UK biobank community cohort.","volume":"75","author":"Kuo","year":"2020","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.bbi.2020.05.037","article-title":"Subjective neurological symptoms frequently occur in patients with SARS-CoV2 infection.","volume":"88","author":"Liguori","year":"2020","journal-title":"Brain Behav. Immun."},{"key":"B26","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1016\/j.jinf.2020.06.072","article-title":"Elevation of ACE2 as a SARS-CoV-2 entry receptor gene expression in Alzheimer\u2019s disease.","volume":"81","author":"Lim","year":"2020","journal-title":"J. Infect."},{"key":"B27","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1001\/jamaneurol.2020.1127","article-title":"Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China.","volume":"77","author":"Mao","year":"2020","journal-title":"JAMA Neurol."},{"key":"B28","doi-asserted-by":"crossref","DOI":"10.1186\/s13195-020-00744-w","article-title":"Cognitive impact of COVID-19: looking beyond the short term.","volume":"12","author":"Miners","year":"2020","journal-title":"Alzheimers Res. Ther."},{"key":"B29","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1002\/alz.12143","article-title":"Tackling challenges in care of Alzheimer\u2019s disease and other dementias amid the COVID-19 pandemic, now and in the future.","volume":"16","author":"Mok","year":"2020","journal-title":"Alzheimers Dement"},{"key":"B30","article-title":"ACE\/ACE2 ratio: a key also in 2019 coronavirus disease (Covid-19)?","volume":"7","author":"Pagliaro","year":"2020","journal-title":"Front. Med. (Lausanne)"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1007\/s12035-020-02177-w","article-title":"Neurobiochemical cross-talk between COVID-19 and Alzheimer\u2019s disease.","volume":"58","author":"Rahman","year":"2021","journal-title":"Mol. Neurobiol."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.636754","article-title":"Circulating angiotensin-(1\u20137) is reduced in Alzheimer\u2019s disease patients and correlates with white matter abnormalities: results from a pilot study.","volume":"15","author":"Ribeiro","year":"2021","journal-title":"Front. Neurosci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"484","DOI":"10.2174\/0929866527666191230103739","article-title":"Renin-angiotensin system and Alzheimer\u2019s disease pathophysiology: from the potential interactions to therapeutic perspectives.","volume":"27","author":"Ribeiro","year":"2020","journal-title":"Protein Pept. Lett."},{"key":"B34","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.2174\/1389450117666160727142401","article-title":"The anti-inflammatory potential of ACE2\/angiotensin-(1-7)\/mas receptor axis: evidence from basic and clinical research.","volume":"18","author":"Rodrigues Prestes","year":"2017","journal-title":"Curr. Drug Targets"},{"key":"B35","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20202135","article-title":"Neuroinvasion of SARS-CoV-2 in human and mouse brain.","volume":"218","author":"Song","year":"2021","journal-title":"J. Exp. Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"4825","DOI":"10.1111\/bph.15082","article-title":"A hypothesis for pathobiology and treatment of COVID-19: The centrality of ACE1\/ACE2 imbalance.","volume":"177","author":"Sriram","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/sj.bjp.0705262","article-title":"Brain renin-angiotensin system dysfunction in hypertension: recent advances and perspectives.","volume":"139","author":"Veerasingham","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"10505","DOI":"10.1096\/fj.202001020r","article-title":"The ACE2-deficient mouse: a model for a cytokine storm-driven inflammation.","volume":"34","author":"Wang","year":"2020","journal-title":"Faseb. J."},{"key":"B39","doi-asserted-by":"publisher","first-page":"469","DOI":"10.3233\/jad-181035","article-title":"Contributions by the brain renin-angiotensin system to memory, cognition, and Alzheimer\u2019s disease.","volume":"67","author":"Wright","year":"2019","journal-title":"J. Alzheimers Dis."},{"key":"B40","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.bbi.2020.03.031","article-title":"Nervous system involvement after infection with COVID-19 and other coronaviruses.","volume":"87","author":"Wu","year":"2020","journal-title":"Brain Behav. Immun."},{"key":"B41","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.jalz.2018.10.006","article-title":"Quantitative proteomics reveals distinct composition of amyloid plaques in Alzheimer\u2019s disease.","volume":"15","author":"Xiong","year":"2019","journal-title":"Alzheimers Dement"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/s0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2021.684874\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T04:33:17Z","timestamp":1624595597000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2021.684874\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,25]]},"references-count":42,"alternative-id":["10.3389\/fcell.2021.684874"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2021.684874","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,25]]},"article-number":"684874"}}